Stéphanie Gofflot
- Genetics top 10%
-
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 2
-
- Prion Diseases and Protein Misfolding 3
- Glycosylation and Glycoproteins Research 1
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
-
- Tissue Engineering and Regenerative Medicine 2
-
- Dermatological and COVID-19 studies 2
Stéphanie Gofflot
20 papers receiving 504 citations
Peers
Comparison fields: 5 of 76
- Genetics 85
- Oncology 159
- Cancer Research 65
- Biomaterials 46
- Molecular Biology 239
Countries citing papers authored by Stéphanie Gofflot
This map shows the geographic impact of Stéphanie Gofflot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Gofflot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Gofflot more than expected).
Fields of papers citing papers by Stéphanie Gofflot
This network shows the impact of papers produced by Stéphanie Gofflot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Gofflot. The network helps show where Stéphanie Gofflot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stéphanie Gofflot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2020 | 28 | |
| 10 | 2018 | 49 | |
| 11 | 2017 | 16 | |
| 12 | 2017 | 27 | |
| 13 | 2016 | 19 | |
| 14 | 2015 | 102 | |
| 15 | 2012 | 26 | |
| 16 | 2008 | 5 | |
| 17 | 2006 | 110 | |
| 18 | 2005 | 29 | |
| 19 | 2004 | 27 | |
| 20 | 2003 | 49 |
About Stéphanie Gofflot
Stéphanie Gofflot is a scholar working on Dermatology, Oncology and Infectious Diseases, having authored 20 papers that have together received 511 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Prion Diseases and Protein Misfolding (3 papers), COVID-19 Clinical Research Studies (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Dermatological and COVID-19 studies (2 papers), Cancer Cells and Metastasis (2 papers), HER2/EGFR in Cancer Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Genetics (85 citations), Oncology (159 citations) and Cancer Research (65 citations). Stéphanie Gofflot has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Philippe Delvenne, Ernst Heinen, Vincent Castronovo, Brunella Costanza, Willy Zorzi, Akeila Bellahcène, Douglas Vernimmen, Madeleine Grooteclaes, Rosita Winkler and Dominique Begon. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.